The Relationship Between Blood Glucose and Autoantibodies

Type 1 diabetes (T1D) develops when the immune system attacks the pancreas’s insulin-producing beta cells, raising blood glucose levels and eventually requiring insulin treatment. While the disease is usually diagnosed in childhood, researchers are still uncovering how and when the disease process begins.

A study published in The Journal of Clinical Investigation tracked 1,050 infants at genetic risk for type 1 diabetes from 4 months to 3.5 years of age. Researchers measured blood glucose alongside autoantibodies targeting beta cells.

Some children later developed T1D, but the key discovery was that blood glucose began rising after meals even before autoantibodies were detectable.

This suggests there may be an early trigger that impairs beta cells first, followed by the immune system’s autoantibody response. As autoantibody levels rose, blood glucose also increased, pointing to progressive immune-mediated beta-cell damage.

These findings mark an important step toward earlier detection of type 1 diabetes. In the future, they may help identify at-risk children sooner and open the door to strategies aimed at stopping beta-cell destruction before insulin therapy becomes necessary.

Citation:

Warncke, K., et al. (2022). Elevations in blood glucose before and after the appearance of islet autoantibodies in children. The Journal of clinical investigation, 132(20), e162123. https://doi.org/10.1172/JCI162123